Skip to content

Application of Indocyanine Green in Robotic-Assisted Partial Nephrectomy: A Single-center, Prospective Randomized Controlled Study

Application of Indocyanine Green in Robotic-Assisted Partial Nephrectomy: A Single-center, Prospective Randomized Controlled Study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084134
Enrollment
Unknown
Registered
2024-05-11
Start date
2024-05-14
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Cancer

Interventions

Traditional robotic-assisted partial nephrectomy group:Traditional robotic-assisted partial nephrectomy
ICG fluorescence navigation system-assisted robotic partial nephrectomy group:ICG fluorescence navigation system-assisted robotic partial nephrectomy

Sponsors

The First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) The patient signs the "informed consent form"; (2) Age 18-80 years old, male or female; (3) The preoperative routine examination has been completed (chest CT, electrocardiogram, cardiac color ultrasound), no serious underlying diseases, and can tolerate robot-assisted partial nephrectomy after clinical evaluation.

Exclusion criteria

Exclusion criteria: (1) Patients who are allergic to indocyanine green or iodine or have allergic constitution; (2) Elderly patients with serious underlying diseases such as cardiovascular and cerebrovascular diseases, abnormal coagulation function, inability to tolerate surgery or hospitalization due to underlying diseases; (3) HIV-infected patients or patients with active hepatitis; (4) Participated in other clinical trials within the past 30 days; (5) Patients with mental illness, cognitive impairment, inability to understand the trial protocol and side effects, and inability to complete the trial and follow-up work; (6) Those who lack personal freedom and independent civil capacity.

Design outcomes

Primary

MeasureTime frame
Positive rate of surgical margins;Perioperative complications;Renal function at 1 year postoperatively;

Secondary

MeasureTime frame
Survival at 5 years postoperatively;Perioperative information;

Countries

China

Contacts

Public ContactNing Xu

The First Affiliated Hospital of Fujian Medical University

drxun@fjmu.edu.cn+86 132 3590 7575

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026